Melanocortin receptor-specific spiro-piperidine compounds
US8263608B2 · kind B2 · utility
8Cited by
7References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2011 |
| Grant date | Sep 11, 2012 |
| Priority date | — |
| Expiry date | Mar 29, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Melanocortin receptor-specific compounds of formula I below:wherein the variables are as defined in the specification, and enantiomers, diastereomers and pharmaceutically acceptable salts thereof. Compounds disclosed herein bind to one or more melanocortin receptors and may be an agonist, a partial agonist, an antagonist, an inverse agonist or an antagonist of an inverse agonist as to one or more melanocortin receptors, and may be employed for treatment of one or more melanocortin receptor-associated conditions or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.